Impact of early applied upper limb stimulation: The EXPLICIT-stroke programme design

<p>Abstract</p> <p>Background</p> <p>Main claims of the literature are that functional recovery of the paretic upper limb is mainly defined within the first month post stroke and that rehabilitation services should preferably be applied intensively and in a task-oriente...

Full description

Bibliographic Details
Main Authors: Lindeman Eline, van Kuijk Annet A, Geurts Alexander CH, Lankhorst Guus J, van Wegen Erwin E, Meskers Carel GM, Kwakkel Gert, Visser-Meily Anne, de Vlugt Erwin, Arendzen J Hans
Format: Article
Language:English
Published: BMC 2008-12-01
Series:BMC Neurology
Online Access:http://www.biomedcentral.com/1471-2377/8/49
_version_ 1818472774153273344
author Lindeman Eline
van Kuijk Annet A
Geurts Alexander CH
Lankhorst Guus J
van Wegen Erwin E
Meskers Carel GM
Kwakkel Gert
Visser-Meily Anne
de Vlugt Erwin
Arendzen J Hans
author_facet Lindeman Eline
van Kuijk Annet A
Geurts Alexander CH
Lankhorst Guus J
van Wegen Erwin E
Meskers Carel GM
Kwakkel Gert
Visser-Meily Anne
de Vlugt Erwin
Arendzen J Hans
author_sort Lindeman Eline
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Main claims of the literature are that functional recovery of the paretic upper limb is mainly defined within the first month post stroke and that rehabilitation services should preferably be applied intensively and in a task-oriented way within this particular time window. EXplaining PLastICITy after stroke (acronym EXPLICIT-stroke) aims to explore the underlying mechanisms of post stroke upper limb recovery. Two randomized single blinded trials form the core of the programme, investigating the effects of early modified Constraint-Induced Movement Therapy (modified CIMT) and EMG-triggered Neuro-Muscular Stimulation (EMG-NMS) in patients with respectively a favourable or poor probability for recovery of dexterity.</p> <p>Methods/design</p> <p>180 participants suffering from an acute, first-ever ischemic stroke will be recruited. Functional prognosis at the end of the first week post stroke is used to stratify patient into a poor prognosis group for upper limb recovery (N = 120, A2 project) and a group with a favourable prognosis (N = 60, A1 project). Both groups will be randomized to an experimental arm receiving respectively modified CIMT (favourable prognosis) or EMG-NMS (poor prognosis) for 3 weeks or to a control arm receiving usual care. Primary outcome variable will be the Action Research Arm Test (ARAT), assessed at 1,2,3,4,5, 8, 12 and 26 weeks post stroke. To study the impact of modified CIMT or EMG-NMS on stroke recovery mechanisms i.e. neuroplasticity, compensatory movements and upper limb neuromechanics, 60 patients randomly selected from projects A1 and A2 will undergo TMS, kinematical and haptic robotic measurements within a repeated measurement design. Additionally, 30 patients from the A1 project will undergo fMRI at baseline, 5 and 26 weeks post stroke.</p> <p>Conclusion</p> <p>EXPLICIT stroke is a 5 year translational research programme which main aim is to investigate the effects of early applied intensive intervention for regaining dexterity and to explore the underlying mechanisms that are involved in regaining upper limb function after stroke. EXPLICIT-stroke will provide an answer to the key question whether therapy induced improvements are due to either a reduction of basic motor impairment by neural repair i.e. restitution of function and/or the use of behavioural compensation strategies i.e. substitution of function.</p> <p>EXPLICIT is registered at the Netherlands Trial Register (NTR, <url>http://www.trialregister.nl</url>., TC 1424)</p>
first_indexed 2024-04-14T04:13:16Z
format Article
id doaj.art-b210a93d7dab474ba2ab4c6446959e09
institution Directory Open Access Journal
issn 1471-2377
language English
last_indexed 2024-04-14T04:13:16Z
publishDate 2008-12-01
publisher BMC
record_format Article
series BMC Neurology
spelling doaj.art-b210a93d7dab474ba2ab4c6446959e092022-12-22T02:13:04ZengBMCBMC Neurology1471-23772008-12-01814910.1186/1471-2377-8-49Impact of early applied upper limb stimulation: The EXPLICIT-stroke programme designLindeman Elinevan Kuijk Annet AGeurts Alexander CHLankhorst Guus Jvan Wegen Erwin EMeskers Carel GMKwakkel GertVisser-Meily Annede Vlugt ErwinArendzen J Hans<p>Abstract</p> <p>Background</p> <p>Main claims of the literature are that functional recovery of the paretic upper limb is mainly defined within the first month post stroke and that rehabilitation services should preferably be applied intensively and in a task-oriented way within this particular time window. EXplaining PLastICITy after stroke (acronym EXPLICIT-stroke) aims to explore the underlying mechanisms of post stroke upper limb recovery. Two randomized single blinded trials form the core of the programme, investigating the effects of early modified Constraint-Induced Movement Therapy (modified CIMT) and EMG-triggered Neuro-Muscular Stimulation (EMG-NMS) in patients with respectively a favourable or poor probability for recovery of dexterity.</p> <p>Methods/design</p> <p>180 participants suffering from an acute, first-ever ischemic stroke will be recruited. Functional prognosis at the end of the first week post stroke is used to stratify patient into a poor prognosis group for upper limb recovery (N = 120, A2 project) and a group with a favourable prognosis (N = 60, A1 project). Both groups will be randomized to an experimental arm receiving respectively modified CIMT (favourable prognosis) or EMG-NMS (poor prognosis) for 3 weeks or to a control arm receiving usual care. Primary outcome variable will be the Action Research Arm Test (ARAT), assessed at 1,2,3,4,5, 8, 12 and 26 weeks post stroke. To study the impact of modified CIMT or EMG-NMS on stroke recovery mechanisms i.e. neuroplasticity, compensatory movements and upper limb neuromechanics, 60 patients randomly selected from projects A1 and A2 will undergo TMS, kinematical and haptic robotic measurements within a repeated measurement design. Additionally, 30 patients from the A1 project will undergo fMRI at baseline, 5 and 26 weeks post stroke.</p> <p>Conclusion</p> <p>EXPLICIT stroke is a 5 year translational research programme which main aim is to investigate the effects of early applied intensive intervention for regaining dexterity and to explore the underlying mechanisms that are involved in regaining upper limb function after stroke. EXPLICIT-stroke will provide an answer to the key question whether therapy induced improvements are due to either a reduction of basic motor impairment by neural repair i.e. restitution of function and/or the use of behavioural compensation strategies i.e. substitution of function.</p> <p>EXPLICIT is registered at the Netherlands Trial Register (NTR, <url>http://www.trialregister.nl</url>., TC 1424)</p>http://www.biomedcentral.com/1471-2377/8/49
spellingShingle Lindeman Eline
van Kuijk Annet A
Geurts Alexander CH
Lankhorst Guus J
van Wegen Erwin E
Meskers Carel GM
Kwakkel Gert
Visser-Meily Anne
de Vlugt Erwin
Arendzen J Hans
Impact of early applied upper limb stimulation: The EXPLICIT-stroke programme design
BMC Neurology
title Impact of early applied upper limb stimulation: The EXPLICIT-stroke programme design
title_full Impact of early applied upper limb stimulation: The EXPLICIT-stroke programme design
title_fullStr Impact of early applied upper limb stimulation: The EXPLICIT-stroke programme design
title_full_unstemmed Impact of early applied upper limb stimulation: The EXPLICIT-stroke programme design
title_short Impact of early applied upper limb stimulation: The EXPLICIT-stroke programme design
title_sort impact of early applied upper limb stimulation the explicit stroke programme design
url http://www.biomedcentral.com/1471-2377/8/49
work_keys_str_mv AT lindemaneline impactofearlyappliedupperlimbstimulationtheexplicitstrokeprogrammedesign
AT vankuijkanneta impactofearlyappliedupperlimbstimulationtheexplicitstrokeprogrammedesign
AT geurtsalexanderch impactofearlyappliedupperlimbstimulationtheexplicitstrokeprogrammedesign
AT lankhorstguusj impactofearlyappliedupperlimbstimulationtheexplicitstrokeprogrammedesign
AT vanwegenerwine impactofearlyappliedupperlimbstimulationtheexplicitstrokeprogrammedesign
AT meskerscarelgm impactofearlyappliedupperlimbstimulationtheexplicitstrokeprogrammedesign
AT kwakkelgert impactofearlyappliedupperlimbstimulationtheexplicitstrokeprogrammedesign
AT vissermeilyanne impactofearlyappliedupperlimbstimulationtheexplicitstrokeprogrammedesign
AT devlugterwin impactofearlyappliedupperlimbstimulationtheexplicitstrokeprogrammedesign
AT arendzenjhans impactofearlyappliedupperlimbstimulationtheexplicitstrokeprogrammedesign